EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Size Does Matter! Prioritizing Rare Diseases for Luck Egalitarian Reasons

Didde Boisen Andersen iD, Andreas Brøgger Albertsen iD, Sarah Wadmann iD, Mickael Bech

Bioethics · 2026

DOI: 10.1111/bioe.70136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioethics, 2026. Verfasst von Didde Boisen Andersen und 3 weiteren Autor:innen. Beteiligte Einrichtung: VIVE-The Danish Center for Social Science Research, Aabyhoej, Denmark. Hauptthemen laut MEDLINE: Rare Diseases, Health Priorities, Social Justice, Health Care Rationing. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: LÆge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat, Danmarks Grundforsknings fond, Danmarks Frie Forskningsfond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rarity provides a challenging case for contemporary priority setting. On the one hand, many philosophers and economists argue that rarity has no inherent moral value, and thus that rare diseases merit no special treatment in priority setting decisions simply because they are rare. On the other hand, existing priority‐setting practices demonstrate a higher willingness to pay for rare disease treatments. We argue that special priority for rare diseases might be justified on egalitarian grounds. Specifically, we develop and defend what we call the “bad numbers luck” argument for prioritizing rare diseases. This is a variant of the luck egalitarian idea of bad price luck. We conclude by discussing how higher willingness to pay, adjusted priority‐setting processes, and a broader societal focus on rare diseases could address such injustices. Recognising bad numbers luck clarifies the relationship between fairness and efficiency in health care priority setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesHealth PrioritiesSocial JusticeHealth Care RationingHumansDecision MakingOrphan Drug Production

Stichwörter der Autor:innen

Justicebad price luckformal equalityluck egalitarianismorphan drugspriority settingrare diseases

Autor:innen und Institutionen

  • VIVE-The Danish Center for Social Science Research, Aabyhoej, Denmark.
  • Department of Political Science and Centre for the Experimental-Philosophical Study of Discrimination (CEPDISC), Aarhus University, Aarhus C, Denmark.
  • VIVE-The Danish Center for Social Science Research, Copenhagen, Denmark.
  • Department of Political Science and Public Management, University of Southern Denmark, SDU, Odense, Denmark.

ORCID-Profile: Didde Boisen Andersen, Andreas Brøgger Albertsen, Sarah Wadmann

Förderung

  • LÆge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat
  • Danmarks Grundforsknings fond
  • Danmarks Frie Forskningsfond
  • Læge Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat

Zitieren

APA

Andersen, D. B., Albertsen, A. B., Wadmann, S., & Bech, M. (2026). Size Does Matter! Prioritizing Rare Diseases for Luck Egalitarian Reasons. Bioethics. https://doi.org/10.1111/bioe.70136

Vancouver

Andersen DB, Albertsen AB, Wadmann S, Bech M. Size Does Matter! Prioritizing Rare Diseases for Luck Egalitarian Reasons. Bioethics. 2026. doi:10.1111/bioe.70136

BibTeX
@article{Andersen2026,
  author = {Andersen, Didde Boisen and Albertsen, Andreas Brøgger and Wadmann, Sarah and Bech, Mickael},
  title = {Size Does Matter! Prioritizing Rare Diseases for Luck Egalitarian Reasons},
  journal = {Bioethics},
  year = {2026},
  doi = {10.1111/bioe.70136}
}
Kostenlos starten →